Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02486250 · ClinicalTrials.gov registry record
Online Neuropsychological Test Validation Project With Imaging Pilot
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 982
- Enrollment target
NCT02486250: Completed study, sponsored by University of California, San Francisco.
NCT02486250 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 982 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02486250 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 982 participants
- Enrollment target
Study Summary
This is a five year study conducted in cooperation with the Brain Health Registry (BHR), an internet-based registry which enrolls adult volunteers in order to facilitate clinical trials for the prevention of Alzheimer's disease (AD). The investigators goal is to validate the Brain Health Registry's online cognitive measures developed by Lumosity. Investigators will meet this goal by collecting data from the newly developed the BHR online cognitive screening battery along with standardized measures of memory, attention, executive functioning and speed of information processing currently used in clinical trials for Alzheimer's disease.
Primary Outcome
Number of people recruited online for in-clinic study will help determine the feasibility of using the Brain Health Registry as a recruitment source for an in-clinic study at the SFVAMC.
Interventions
- OTHER Validation Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 982 participants |
| Start Date | 2015-01 |
| Est. Completion | 2021-03 |
What the finished NCT02486250 record still lists
NCT02486250 is an observational study that tracks outcomes without assigning an intervention. The registered 982 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Validation Study is the first listed.
NCT02486250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02486250 about?
NCT02486250 is a clinical study titled "Online Neuropsychological Test Validation Project With Imaging Pilot". This is a five year study conducted in cooperation with the Brain Health Registry (BHR), an internet-based registry which enrolls adult volunteers in order to facilitate clinical trials for the prevention of Alzheimer's disease (AD). The investigators goal is to validate the Brain Health Registry's ...
What is the current status of trial NCT02486250?
This trial is currently completed. The enrollment target is 982 participants. The study started on 2015-01. Estimated completion is 2021-03.
What interventions are being tested in trial NCT02486250?
The interventions under investigation include: Validation Study (OTHER).
Who is sponsoring clinical trial NCT02486250?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06989437 · 982 participants · Phase 2
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- NCT06959095 · 981 participants · Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- NCT06337097 · 980 participants · NA
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
- NCT07070232 · 980 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia